Platinum Investment Management LTD Centessa Pharmaceuticals PLC Transaction History
Platinum Investment Management LTD
- $1.66 Billion
- Q4 2024
A detailed history of Platinum Investment Management LTD transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Platinum Investment Management LTD holds 370,278 shares of CNTA stock, worth $6.52 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
370,278
Previous 429,701
13.83%
Holding current value
$6.52 Million
Previous $6.87 Million
9.72%
% of portfolio
0.37%
Previous 0.32%
Shares
7 transactions
Others Institutions Holding CNTA
# of Institutions
107Shares Held
119MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$352 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$176 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$171 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$111 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$105 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.66B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...